Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer
It was demonstrated that the survival outcomes for select patients with Stage IV breast cancer have significant convergence in OS with some patients with Stage III disease. These findings may be important for patient counseling, treatment approaches, and clinical trial design.
Authors
- E. Shelley Hwang (ORCID: https://orcid.org/0000-0002-8571-1148)
- Rani Bansal
- Ton Wang (ORCID: https://orcid.org/0000-0003-0437-3771)
- Jennifer Kay Plichta (ORCID: https://orcid.org/0000-0002-7411-0558)
- Gayle DiLalla (ORCID: https://orcid.org/0000-0002-0962-6734)
- Samantha Marie Thomas (ORCID: https://orcid.org/0000-0002-1561-9303)
- Hannah E. Woriax (ORCID: https://orcid.org/0000-0002-8746-6457)
- Anna D. Louie (ORCID: https://orcid.org/0000-0001-8394-6106)
- Laura Horst Rosenberger (ORCID: https://orcid.org/0000-0002-6829-6747)
- Michael S. Lee (ORCID: https://orcid.org/0000-0001-8407-3423)
- Kendra J. Modell Parrish
Institutions
- Duke University (US)
- Duke Medical Center (US)
- Duke University Hospital (US)
Publication Details
- Journal
- Cancer
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1002/cncr.35891
- Citations
- 3
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.81
Funders
- National Institutes of Health